Captopril and Hydrochlorothiazide (Mylan Phamaceuticals Inc.)
Welcome to the PulseAid listing for the Captopril and Hydrochlorothiazide drug offered from Mylan Phamaceuticals Inc.. This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Phamaceuticals Inc. |
| NON-PROPRIETARY NAME: | captopril and hydrochlorothiazide |
| SUBSTANCE NAME: | CAPTOPRIL; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 1997-12-29 |
| END MARKETING DATE: | 0000-00-00 |
Captopril and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Captopril and Hydrochlorothiazide from Mylan Phamaceuticals Inc. |
| LABELER NAME: | Mylan Phamaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25; 15(mg/1; mg/1) |
| START MARKETING DATE: | 1997-12-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-0081_3f830175-e2d8-410d-b25a-49e4cc3c97e4 |
| PRODUCT NDC: | 0378-0081 |
| APPLICATION NUMBER: | ANDA074896 |
Other CAPTOPRIL; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
